Factors and ranges considered in multivariate sensitivity analysis

FactorRange
Hazard of cardiovascular disease without pravastatin0.001 to 0.1 (per person year)
Age45-65 years
Subsequent costs (per event)£0 to £6500
Monitoring costs per month£0 to £10
Efficacy (% reduction in risk)10% to 43%
Definition of cardiovascular diseaseAll definitions